{"title":"一类抗心律失常药物激发试验","authors":"M. Antz","doi":"10.1093/MED/9780198779742.003.0013","DOIUrl":null,"url":null,"abstract":"The Brugada syndrome is associated with potentially lethal arrhythmias and sudden cardiac death. The diagnosis is made from the surface ECG. In suspicious but not typical ECGs, intravenous administration of class 1 anti-arrhythmic drugs (i.e. sodium channel blocking agents such as ajmaline, flecainide, or procainamide) can be performed for diagnostic reasons.","PeriodicalId":143273,"journal":{"name":"The ESC Textbook of Sports Cardiology","volume":"8 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Class 1 anti-arrhythmic drug provocation test\",\"authors\":\"M. Antz\",\"doi\":\"10.1093/MED/9780198779742.003.0013\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The Brugada syndrome is associated with potentially lethal arrhythmias and sudden cardiac death. The diagnosis is made from the surface ECG. In suspicious but not typical ECGs, intravenous administration of class 1 anti-arrhythmic drugs (i.e. sodium channel blocking agents such as ajmaline, flecainide, or procainamide) can be performed for diagnostic reasons.\",\"PeriodicalId\":143273,\"journal\":{\"name\":\"The ESC Textbook of Sports Cardiology\",\"volume\":\"8 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The ESC Textbook of Sports Cardiology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1093/MED/9780198779742.003.0013\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The ESC Textbook of Sports Cardiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/MED/9780198779742.003.0013","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The Brugada syndrome is associated with potentially lethal arrhythmias and sudden cardiac death. The diagnosis is made from the surface ECG. In suspicious but not typical ECGs, intravenous administration of class 1 anti-arrhythmic drugs (i.e. sodium channel blocking agents such as ajmaline, flecainide, or procainamide) can be performed for diagnostic reasons.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
